Erin HeinzenView profile
Associate Professor
Erin Heinzen is an Associate Professor at the UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, with a joint appointment in the UNC Department of Genetics. She holds a Pharm.D. and Ph.D. from the University of North Carolina at Chapel Hill, followed by postdoctoral training at Duke University. Her research focuses on the genetic and genomic basis of epilepsy disorders, particularly somatic mutations and transcriptomic regulation in neurological diseases. Education: Pharm.D., University of North Carolina at Chapel Hill (2001) Ph.D., Pharmaceutical Sciences, University of North Carolina Chapel Hill (2004) Research Interests: Dr. Heinzen’s lab investigates somatic mutations in epilepsy and brain malformations, using induced pluripotent stem cells and advanced sequencing technologies. Key projects include studying SLC35A2 variants in intractable epilepsy and analyzing transcriptomic changes in brain tissue. Her work has identified 15 epilepsy genes, including the gene for Alternating Hemiplegia of Childhood. Grants & Awards: NIH-funded research, including $7M in collaborative grants to study genetic variants in epilepsy. Active in consortia like Epi4K and ILAE. Labs & Teams: The Heinzen Lab collaborates with neurology, neuropathology, and neurosurgery groups globally, advancing neurogenetics and treatment approaches for intractable seizures.







